Sepsis: all 1,946 studies

Page 19 of 20. Open to participants first (471), then studies with results posted, then the rest; newest registration first within each.

• Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream InfectionsCompletedNCT00870623
• Defects in Opsonophagocytosis in Premature InfantsCompletedNCT00866567
• Circulating microRNAs as Biomarkers of SepsisCompletedNCT00862290
• Neonatal Sepsis and GBS Carriage StudyCompletedNCT00861055
• The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With Percutaneous Endoscopic Gastrostomy PlacementStatus unknownNCT00859235Phase 3
• Neonatal Procalcitonin Intervention StudyStatus unknownNCT00854932Not applicable
• Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in BangladeshCompletedNCT00844337Not applicable
• Surveillance for Nosocomial Infections in Pediatric Cancer PatientsStatus unknownNCT00843804
• The Ohio State University Sepsis RegistryTerminatedNCT00837421
• Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney InjuryStatus unknownNCT00837057Phase 4
• Autonomic Nervous System Alteration Induce by Sepsis: Assessment and Prognosis ImpactCompletedNCT00835913
• Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and SepsisTerminatedNCT00835874Not applicable
• Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe SepsisCompletedNCT00832039Phase 3
• Biological Markers to Identify Early Sepsis and Acute Lung InjuryCompletedNCT00825357
• Rapid Administration of Insulin in SepsisCompletedNCT00823108Phase 1
• Fluid Resuscitation in Early Septic ShockCompletedNCT00819416Phase 2
• Extracorporeal Immune Support System (EISS) for the Treatment of Septic PatientsCompletedNCT00818597Phase 1/2
• Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU PatientsCompletedNCT00811629
• Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid LeukemiaCompletedNCT00806325
• The Biomarker and Cardiac Function in SepsisStatus unknownNCT00800631
• Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe SepsisCompletedNCT00799916Phase 3
• Dental Study in Cancer Patients With Central Venous CathetersCompletedNCT00798330
• Endothelium in Severe SepsisCompletedNCT00793442
• Arterial Blood Pressure-complexity in Septic PatientsSuspendedNCT00793078
• Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified EtiologyStatus unknownNCT00791310Phase 3
• Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological PatientsCompletedNCT00781040
• Septic Encephalopathy and Late Cognitive DysfunctionCompletedNCT00772096Phase 4
• Uremic Toxins in the Intensive Care Unit (ICU): Patients With SepsisWithdrawnNCT00752245Not applicable
• Presep and Vascath Interaction StudyWithdrawnNCT00739089
• BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill PatientsCompletedNCT00736827
• Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot StudyCompletedNCT00732277Phase 2
• Management of Infants Born to Group B Streptococcus Positive Mothers.CompletedNCT00716781
• Angiotensin in Septic Kidney Injury TrialStatus unknownNCT00711789Phase 2
• Efficacy of Thymosin alpha1 for Severe SepsisCompletedNCT00711620Not applicable
• Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe InfectionsCompletedNCT00709358Phase 4
• Efficacy of Macrolide Immunomodulation in Severe Sepsis.TerminatedNCT00708799Phase 2
• Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing EnterocolitisCompletedNCT00707785Phase 3
• Volume Replacement With Albumin in Severe SepsisCompletedNCT00707122Phase 3
• Evaluation of the Patient Safety Screening Tool (PSST) for SepsisTerminatedNCT00698542
• Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic ShockCompletedNCT00698048
• Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis PatientsStatus unknownNCT00697944Phase 4
• Hydrocortisone for Prevention of Septic ShockCompletedNCT00670254Phase 3
• Acute Phase Proteins as Early Markers in SepsisStatus unknownNCT00641355
• Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe SepsisCompletedNCT00634075Phase 4
• Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe SepsisCompletedNCT00630656Phase 2
• Early Use of Polymyxin B Hemoperfusion in Abdominal SepsisCompletedNCT00629382Phase 4
• A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for DialysisStatus unknownNCT00628680Phase 3
• L-citrulline Supplementation During SepsisStatus unknownNCT00628381Phase 3
• Relationship Between Alcohol Use Disorders and Cortisol Levels in Patients With SepsisCompletedNCT00615862
• A Simple Clinical Tool to Help Assess Patient Volume (Fluid) StatusCompletedNCT00599794
• Infected Elders in the Emergency Department: Outcomes and Processes of CareCompletedNCT00591955
• Muscle Atrophy in SepsisWithdrawnNCT00583206
• An Open Label Study of Severe Sepsis in AdultsCompletedNCT00568893Phase 4
• The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of DeathCompletedNCT00568737Phase 3
• A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in AdultSuspendedNCT00563134Not applicable
• Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting SepsisCompletedNCT00561639
• Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With SepsisCompletedNCT00559130Not applicable
• Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)CompletedNCT00555282Phase 4
• Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis PatientsCompletedNCT00550693Phase 4
• Effect of Taurolidin on Prevention of Bloodstream InfectionTerminatedNCT00545831Not applicable
• Skeletal Muscle and Platelet Mitochondrial Dysfunction During SepsisCompletedNCT00541827
• Cytokine Removal by CRRT in Pediatric SepsisCompletedNCT00537693Not applicable
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT ProtocolCompletedNCT00524290
• Prevention of Infection in Indian Neonates - Phase I Observational StudyCompletedNCT00518609
• Prevention of Infection in Indian Neonates - Phase II Probiotics StudyCompletedNCT00518596Phase 2
• A Study in Sepsis Patients With Renal FailureTerminatedNCT00511186Phase 2
• The Effect of Nitroglycerine on Microcirculatory Abnormalities During SepsisCompletedNCT00493415Phase 3
• Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)CompletedNCT00488917
• Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular CoagulationCompletedNCT00487656Phase 2
• Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric TreatmentCompletedNCT00487019
• Methylene Blue in Sepsis: A Randomized Controlled TrialWithdrawnNCT00486174Not applicable
• Chlorhexidine Swabs Effectiveness in Reducing Blood Stream InfectionsTerminatedNCT00485992
• Alterations of Immunologic Mediators During Severe SepsisTerminatedNCT00484146
• Microcirculation Guided Therapy Versus "Standard Treatment" of Severe SepsisStatus unknownNCT00484133Phase 4
• Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)WithdrawnNCT00472628
• Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic PatientsCompletedNCT00463645
• Statin for Immunomudulation in SepsisStatus unknownNCT00452608Phase 2
• Pharmacokinetic of Ceftriaxone in Septic ICU PatientsStatus unknownNCT00449800Phase 4
• The Utility of Ischemia Modified Albumin (IMA) in SepsisCompletedNCT00448968
• Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With SepsisCompletedNCT00430859Phase 2
• Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological DiseaseCompletedNCT00413738Phase 3
• Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation MonitoringCompletedNCT00407823Not applicable
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe SepsisCompletedNCT00406198Phase 4
• A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.CompletedNCT00398736
• To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)CompletedNCT00397956Phase 3
• Cortisol Control of Human Inflammatory Responses to EndotoxinCompletedNCT00396344Not applicable
• Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study)Status unknownNCT00389337
• Clinical Trial of the Optimal Endpoint of Early Sepsis ResuscitationCompletedNCT00372502Not applicable
• Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe SepsisWithdrawnNCT00368381Phase 4
• Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ FailureTerminatedNCT00361725
• Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy VolunteersCompletedNCT00360048
• Effect of Rosuvastatin in Abdominal SepsisStatus unknownNCT00357123Phase 2
• The Effects of HIV Protease Inhibitors in Severe SepsisCompletedNCT00346580Phase 1
• Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive WomenCompletedNCT00343317Not applicable
• Protocol-driven Hemodynamic Support for Patients With Septic ShockStatus unknownNCT00335907Not applicable
• ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe SepsisCompletedNCT00334828Phase 3
• Super High-Flux - High Volume Dialysis in Sepsis-Induced Acute Renal FailureCompletedNCT00333593Phase 1/2
• Ontario ICU Clinical Best Practices Demonstration ProjectCompletedNCT00332982Not applicable
• The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of SepsisCompletedNCT00329680Phase 4

← Sepsis overview